Matthew L. Kaplan

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Nuvectis Pharma Inc., 3 years.

3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 11, 2026 Nuvectis Pharma Inc. Grant or award +35,000 โ€” โ€”
Nov 5, 2025 Nuvectis Pharma Inc. Open-market purchase +11,000 $5.84 $64,240
Jun 12, 2025 Nuvectis Pharma Inc. Grant or award +30,000 โ€” โ€”
Jun 13, 2024 Nuvectis Pharma Inc. Grant or award +30,000 โ€” โ€”
Jun 16, 2023 Nuvectis Pharma Inc. Grant or award +18,000 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.